N
Nexaph
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Cagrilintide | B | 10 | 7.2 | 5.3 | 9.3 | 14 Jun 2025 |
| CJC-1295 | C | 6 | 5.3 | 4.7 | 6.8 | 10 Jun 2025 |
| GHK-Cu | C | 5 | 6.6 | 4.3 | 8.2 | 4 Aug 2025 |
| Semaglutide | C | 14 | 6.2 | 4.5 | 7.5 | 11 Jun 2025 |
| Tesamorelin | D | 21 | 7.0 | 3.2 | 9.7 | 29 Jun 2025 |
| BPC-157 | E | 11 | 6.6 | 1.5 | 9.7 | 29 Jun 2025 |
| Ipamorelin | E | 9 | 5.7 | 0.0 | 8.6 | 3 Jul 2025 |
| Retatrutide | E | 82 | 7.3 | 0.0 | 10.0 | 11 Jun 2025 |
| Tirzepatide | E | 42 | 7.3 | 3.0 | 10.0 | 2 Jul 2025 |
| 17a-Methyl-1-Testosterone | B | 13 | 6.5 | 4.3 | 9.4 | 24 May 2026 |
| Anadrol Oil | B | 5 | 5.0 | 3.5 | 7.4 | 24 May 2026 |
| AOD9604 | B | 2 | 6.0 | 5.2 | 6.7 | 24 May 2026 |
| Arimidex (Anastrozole) | B | 3 | 7.7 | 6.0 | 9.1 | 21 May 2026 |
| BAM15 | B | 9 | 6.9 | 4.6 | 9.2 | 26 Jan 2026 |
| BPC-157 Arg Oral | B | 13 | 7.0 | 3.2 | 9.7 | 17 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | B | 6 | 6.5 | 4.8 | 7.7 | 26 Jan 2026 |
| Clenbuterol | B | 12 | 6.7 | 4.1 | 9.6 | 25 May 2026 |
| Dermorphin | B | 7 | 7.1 | 5.5 | 9.0 | 20 May 2026 |
| Dianabol Raw | B | 5 | 7.0 | 5.8 | 8.8 | 20 May 2026 |
| DSIP | B | 5 | 7.2 | 6.0 | 8.3 | 24 May 2026 |
| Estradiol Cypionate | B | 8 | 7.1 | 4.2 | 8.5 | 21 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | B | 11 | 6.7 | 3.1 | 9.0 | 21 May 2026 |
| HCG | B | 11 | 7.2 | 3.9 | 9.6 | 19 Jan 2026 |
| LGD-4033 (Ligandrol) Raw | B | 7 | 7.0 | 6.3 | 8.2 | 19 Jan 2026 |
| Lipo-B 216mg | B | 9 | 7.1 | 5.5 | 10.0 | 21 May 2026 |
| Livagen | X | 1 | 6.8 | 6.8 | 6.8 | 11 Jun 2025 |
| Methylstenbolone | B | 9 | 7.5 | 4.0 | 9.3 | 20 May 2026 |
| MGF | B | 4 | 6.4 | 4.9 | 7.5 | 25 May 2026 |
| Minoxidil Oral | B | 6 | 7.7 | 6.4 | 8.6 | 21 May 2026 |
| MOTS-C | B | 7 | 6.7 | 4.3 | 8.9 | 26 Jan 2026 |
| N-Acetyl Epitalon Amidate | B | 2 | 8.1 | 7.1 | 9.2 | 23 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | B | 8 | 7.1 | 5.0 | 9.9 | 19 Jan 2026 |
| Ostarine (MK-2866) | B | 9 | 7.0 | 4.7 | 8.6 | 24 May 2026 |
| P21 | B | 11 | 7.6 | 4.6 | 10.0 | 25 May 2026 |
| PE 22-28 | B | 8 | 7.0 | 5.6 | 10.0 | 25 May 2026 |
| PEG MGF | B | 8 | 6.8 | 5.0 | 10.0 | 21 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | B | 8 | 6.2 | 3.1 | 9.2 | 24 May 2026 |
| Proviron (Mesterolone) | B | 11 | 8.0 | 6.0 | 9.9 | 20 May 2026 |
| PTD-DBM | B | 3 | 6.0 | 4.3 | 7.8 | 25 May 2026 |
| S-23 Raw | B | 3 | 5.9 | 5.0 | 7.3 | 26 Jan 2026 |
| SNAP-8 | B | 9 | 7.2 | 5.0 | 10.0 | 24 May 2026 |
| T3 (Liothyronine) | B | 15 | 6.6 | 3.7 | 8.8 | 25 May 2026 |
| Tirzepatide 30mg Pen Kit | B | 4 | 7.8 | 6.0 | 9.0 | 24 May 2026 |
| Trenbolone Acetate Raw | B | 15 | 6.7 | 3.1 | 9.6 | 19 Jan 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.4 | 10mg | 12.0mg | +20.3% | 98.61% | Lab C |
| 25 May 2026 | Estradiol Cypionate | 7.5 | 300mg/ml | 366.8mg/ml | +22.3% | 98.88% | Lab F |
| 25 May 2026 | Methylstenbolone | 7.5 | 20mg | 22.2mg | +10.9% | 98.48% | Lab B |
| 25 May 2026 | MOTS-C | 6.6 | 30mg | 31.3mg | +4.2% | 95.12% | Lab A |
| 25 May 2026 | SNAP-8 | 6.9 | 20mg | 24.1mg | +20.3% | 99.73% | Lab A |
| 25 May 2026 | Tirzepatide 30mg Pen Kit | 6.7 | 20mg | 23.6mg | +18.2% | 95.61% | Lab C |
| 24 May 2026 | 17a-Methyl-1-Testosterone | 5.4 | 25mg | 29.9mg | +19.7% | 96.54% | Lab A |
| 24 May 2026 | Clenbuterol | 5.0 | 20mg | 19.4mg | -2.9% | 98.43% | Lab G |
| 24 May 2026 | HCG | 5.5 | 50mg | 48.3mg | -3.3% | 97.18% | Lab B |
| 24 May 2026 | Proviron (Mesterolone) | 7.9 | 10mg | 11.8mg | +18.0% | 99.64% | Lab C |
| 24 May 2026 | BPC-157 | 6.6 | 10mg | 12.6mglabel | 14.7mg | +17.1% | BPC1001212026-18 |
| 24 May 2026 | Tirzepatide | 4.4 | 30mg | (no batch claim) | 53.4mg | +78.0% | NXP-2P3002072026-01 |
| 24 May 2026 | Arimidex (Anastrozole) | 5.8 | 10mg | 10.7mg | +7.3% | 95.83% | Lab D |
| 24 May 2026 | BPC-157 Arg Oral | 9.9 | 100mg | 109.7mg | +9.7% | 96.57% | Lab C |
| 24 May 2026 | Dianabol Raw | 6.9 | 10g | 11.9g | +19.1% | 96.97% | Lab B |
| 24 May 2026 | Minoxidil Oral | 9.0 | 25mg | 30.1mg | +20.4% | 98.75% | Lab F |
| 24 May 2026 | PE 22-28 | 5.0 | 50mg | 62.0mg | +24.0% | 96.62% | Lab F |
| 24 May 2026 | PTD-DBM | 5.3 | 10mg | 10.2mg | +1.7% | 95.51% | Lab D |
| 24 May 2026 | S-23 Raw | 6.6 | 100g | 89.6g | -10.4% | 96.74% | Lab D |
| 24 May 2026 | Trenbolone Acetate Raw | 4.9 | 500g | 567.4g | +13.5% | 95.82% | Lab A |
| 24 May 2026 | Trenbolone Acetate Raw | 8.0 | 1g | 1.0g | -1.8% | 99.12% | Lab G |
| 24 May 2026 | Retatrutide | 8.8 | 12mg | (no batch claim) | 12.9mg | +7.5% | NXP-3P1201092026-01 |
| 24 May 2026 | Retatrutide | 9.3 | 24mg | (no batch claim) | 25.7mg | +7.1% | NXP-3P2401262026-13 |
| 24 May 2026 | Retatrutide | 8.4 | 24mg | 14.1mglabel | 13.6mg | -3.2% | NXP-3P1201092026-01 |
| 24 May 2026 | Dermorphin | 6.7 | 5mg | 4.9mg | -2.3% | 98.06% | Lab A |
| 24 May 2026 | DSIP | 8.3 | 5mg | 5.7mg | +14.0% | 98.76% | Lab B |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.5 | 30mg | 35.9mg | +19.6% | 95.66% | Lab F |
| 24 May 2026 | Methylstenbolone | 7.7 | 100mg | 100.1mg | +0.1% | 99.43% | Lab F |
| 24 May 2026 | Methylstenbolone | 6.2 | 50mg | 45.9mg | -8.2% | 98.46% | Lab G |
| 24 May 2026 | Minoxidil Oral | 7.7 | 20mg | 18.5mg | -7.3% | 97.78% | Lab A |
| 24 May 2026 | Ostarine (MK-2866) | 8.7 | 100mg | 106.9mg | +6.9% | 96.59% | Lab F |
| 24 May 2026 | P21 | 7.1 | 50mg | 58.4mg | +16.7% | 96.54% | Lab D |
| 24 May 2026 | SNAP-8 | 7.0 | 5mg | 4.4mg | -12.4% | 97.39% | Lab B |
| 24 May 2026 | SNAP-8 | 5.5 | 15mg | 13.7mg | -8.9% | 98.93% | Lab A |
| 24 May 2026 | Trenbolone Acetate Raw | 4.9 | 1g | 0.9g | -9.0% | 99.27% | Lab E |
| 24 May 2026 | Tesamorelin | 8.2 | 10mg | 11.9mglabel | 11.7mg | -1.5% | TES1001172026-16 |
| 24 May 2026 | Tirzepatide | 9.3 | 60mg | 69.9mglabel | 65mg | -7.0% | NXP-2p6001152026-01 |
| 24 May 2026 | BAM15 | 8.5 | 25mg | 24.5mg | -2.0% | 95.93% | Lab F |
| 24 May 2026 | BPC-157 Arg Oral | 7.4 | 100mg | 88.6mg | -11.4% | 99.91% | Lab A |
| 24 May 2026 | BPC-157 Arg Oral | 7.0 | 50mg | 54.0mg | +8.1% | 95.02% | Lab F |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.6 | 5mg | 5.2mg | +4.3% | 97.60% | Lab F |
| 24 May 2026 | Clenbuterol | 7.1 | 20mg | 22.4mg | +12.0% | 99.08% | Lab D |
| 24 May 2026 | Methylstenbolone | 7.3 | 20mg | 21.8mg | +9.2% | 97.14% | Lab C |
| 24 May 2026 | MOTS-C | 5.4 | 5mg | 4.6mg | -8.1% | 99.07% | Lab C |
| 24 May 2026 | MOTS-C | 7.1 | 5mg | 6.0mg | +19.6% | 95.06% | Lab D |
| 24 May 2026 | P21 | 9.6 | 15mg | 16.1mg | +7.0% | 97.18% | Lab G |
| 24 May 2026 | P21 | 7.7 | 15mg | 13.1mg | -12.7% | 98.22% | Lab B |
| 24 May 2026 | PEG MGF | 4.8 | 2mg | 2.0mg | +0.0% | 99.47% | Lab C |
| 24 May 2026 | Trenbolone Acetate Raw | 7.0 | 500g | 464.8g | -7.0% | 98.62% | Lab A |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.6 | 50mg | 43.2mg | -13.6% | 97.40% | Lab C |
| 24 May 2026 | LGD-4033 (Ligandrol) Raw | 8.7 | 100g | 116.1g | +16.1% | 96.80% | Lab G |
| 24 May 2026 | Lipo-B 216mg | 7.8 | 300mg/ml | 281.4mg/ml | -6.2% | 99.88% | Lab G |
| 24 May 2026 | Methylstenbolone | 8.1 | 50mg | 46.2mg | -7.6% | 99.46% | Lab E |
| 24 May 2026 | P21 | 8.8 | 5mg | 4.7mg | -5.0% | 98.20% | Lab A |
| 24 May 2026 | PEG MGF | 7.6 | 50mg | 56.9mg | +13.9% | 98.98% | Lab A |
| 24 May 2026 | Proviron (Mesterolone) | 8.2 | 25mg | 23.9mg | -4.5% | 96.20% | Lab D |
| 24 May 2026 | SNAP-8 | 8.4 | 50mg | 46.7mg | -6.6% | 99.43% | Lab D |
| 23 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.9 | 10mg | 9.0mg | -9.6% | 99.92% | Lab A |
| 23 May 2026 | Clenbuterol | 7.8 | 20mg | 19.2mg | -3.8% | 95.42% | Lab A |
| 23 May 2026 | DSIP | 5.5 | 2mg | 2.5mg | +23.6% | 95.64% | Lab E |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 | 2mg | 2.4mg | +20.0% | 98.42% | Lab A |
| 23 May 2026 | Ostarine (MK-2866) | 6.4 | 50mg | 52.9mg | +5.8% | 99.23% | Lab F |
| 23 May 2026 | PE 22-28 | 6.6 | 50mg | 43.8mg | -12.4% | 95.68% | Lab C |
| 23 May 2026 | Proviron (Mesterolone) | 7.6 | 10mg | 10.5mg | +5.5% | 99.11% | Lab G |
| 23 May 2026 | SNAP-8 | 8.2 | 10mg | 8.9mg | -10.8% | 95.83% | Lab C |
| 23 May 2026 | T3 (Liothyronine) | 5.7 | 100mg | 88.4mg | -11.6% | 98.63% | Lab B |
| 23 May 2026 | T3 (Liothyronine) | 5.5 | 20mg | 18.7mg | -6.4% | 99.09% | Lab A |
| 23 May 2026 | 17a-Methyl-1-Testosterone | 5.8 | 10mg | 8.9mg | -10.6% | 98.67% | Lab B |
| 23 May 2026 | Anadrol Oil | 4.0 | 200mg/ml | 198.3mg/ml | -0.8% | 96.21% | Lab C |
| 23 May 2026 | BPC-157 Arg Oral | 5.8 | 100mg | 95.3mg | -4.7% | 95.90% | Lab A |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.6 | 2mg | 2.4mg | +17.9% | 99.47% | Lab B |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.3 | 20mg | 17.5mg | -12.4% | 96.75% | Lab A |
| 23 May 2026 | HCG | 6.0 | 10mg | 8.5mg | -14.7% | 98.32% | Lab D |
| 21 May 2026 | 17a-Methyl-1-Testosterone | 5.5 | 25mg | 25.6mg | +2.6% | 96.69% | Lab D |
| 21 May 2026 | Anadrol Oil | 4.0 | 250mg/ml | 244.6mg/ml | -2.2% | 99.87% | Lab G |
| 21 May 2026 | BPC-157 Arg Oral | 8.3 | 50mg | 52.8mg | +5.6% | 95.30% | Lab A |
| 21 May 2026 | Dermorphin | 7.3 | 2mg | 2.0mg | +1.4% | 97.92% | Lab A |
| 21 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.1 | 15mg | 16.4mg | +9.3% | 97.13% | Lab D |
| 21 May 2026 | HCG | 7.0 | 20mg | 23.4mg | +17.1% | 98.82% | Lab E |
| 21 May 2026 | Lipo-B 216mg | 7.2 | 200mg/ml | 239.4mg/ml | +19.7% | 97.37% | Lab A |
| 21 May 2026 | Lipo-B 216mg | 6.2 | 100mg/ml | 98.9mg/ml | -1.1% | 95.55% | Lab A |
| 21 May 2026 | Lipo-B 216mg | 7.8 | 200mg/ml | 210.0mg/ml | +5.0% | 99.99% | Lab F |
| 21 May 2026 | MOTS-C | 5.9 | 30mg | 30.6mg | +1.8% | 96.05% | Lab G |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.1 | 30mg | 26.3mg | -12.4% | 96.23% | Lab B |
| 21 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.3 | 10g | 12.4g | +24.0% | 99.94% | Lab E |
| 21 May 2026 | Proviron (Mesterolone) | 9.4 | 10mg | 9.2mg | -7.5% | 97.64% | Lab D |
| 21 May 2026 | S-23 Raw | 7.9 | 500g | 505.2g | +1.0% | 96.46% | Lab D |
| 21 May 2026 | Trenbolone Acetate Raw | 6.4 | 5g | 5.2g | +3.7% | 98.58% | Lab F |
| 21 May 2026 | Arimidex (Anastrozole) | 8.9 | 100mg | 88.3mg | -11.7% | 98.22% | Lab F |
| 21 May 2026 | Clenbuterol | 4.9 | 50mg | 50.3mg | +0.6% | 98.65% | Lab F |
| 21 May 2026 | HCG | 8.1 | 30mg | 33.7mg | +12.3% | 97.70% | Lab D |
| 21 May 2026 | Lipo-B 216mg | 9.3 | 250mg/ml | 248.4mg/ml | -0.6% | 99.15% | Lab C |
| 21 May 2026 | PEG MGF | 7.5 | 20mg | 18.5mg | -7.5% | 96.24% | Lab F |
| 21 May 2026 | Proviron (Mesterolone) | 8.4 | 20mg | 19.5mg | -2.5% | 96.59% | Lab C |
| 21 May 2026 | Trenbolone Acetate Raw | 4.5 | 100g | 106.0g | +6.0% | 97.54% | Lab E |
| 21 May 2026 | Trenbolone Acetate Raw | 7.2 | 500g | 485.2g | -3.0% | 97.47% | Lab D |
| 20 May 2026 | 17a-Methyl-1-Testosterone | 4.0 | 50mg | 57.0mg | +14.0% | 97.48% | Lab C |
| 20 May 2026 | BAM15 | 5.0 | 100mg | 92.8mg | -7.2% | 99.70% | Lab E |
| 20 May 2026 | BAM15 | 4.8 | 100mg | 95.1mg | -4.9% | 98.48% | Lab C |
| 20 May 2026 | BPC-157 Arg Oral | 5.5 | 25mg | 22.7mg | -9.2% | 98.41% | Lab D |
| 20 May 2026 | Dermorphin | 8.5 | 10mg | 8.7mg | -13.2% | 99.90% | Lab E |
| 20 May 2026 | LGD-4033 (Ligandrol) Raw | 6.2 | 100g | 87.4g | -12.6% | 99.86% | Lab C |
| 20 May 2026 | Minoxidil Oral | 7.3 | 50mg | 59.6mg | +19.3% | 96.58% | Lab A |
| 20 May 2026 | MOTS-C | 8.7 | 5mg | 5.7mg | +14.7% | 99.96% | Lab D |
| 20 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 | 50mg | 51.7mg | +3.4% | 98.58% | Lab F |
| 20 May 2026 | Ostarine (MK-2866) | 9.7 | 10mg | 11.3mg | +13.1% | 95.27% | Lab E |
| 19 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.3 | 30mg | 28.0mg | -6.5% | 99.03% | Lab D |
| 19 May 2026 | Clenbuterol | 6.7 | 100mg | 121.0mg | +21.0% | 96.74% | Lab E |
| 19 May 2026 | Estradiol Cypionate | 6.4 | 100mg/ml | 95.7mg/ml | -4.3% | 98.83% | Lab F |
| 19 May 2026 | HCG | 6.0 | 10mg | 10.7mg | +7.0% | 96.59% | Lab G |
| 19 May 2026 | Lipo-B 216mg | 6.1 | 100mg/ml | 86.3mg/ml | -13.7% | 97.20% | Lab D |
| 19 May 2026 | PEG MGF | 6.7 | 15mg | 14.5mg | -3.1% | 98.84% | Lab F |
| 19 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.8 | 1g | 1.1g | +9.1% | 98.77% | Lab G |
| 19 May 2026 | Proviron (Mesterolone) | 8.2 | 25mg | 25.7mg | +2.9% | 98.92% | Lab F |
| 19 May 2026 | PTD-DBM | 5.8 | 5mg | 5.2mg | +3.2% | 99.93% | Lab D |
| 19 May 2026 | T3 (Liothyronine) | 6.3 | 20mg | 24.8mg | +24.1% | 98.68% | Lab G |
| 19 May 2026 | Trenbolone Acetate Raw | 5.4 | 1g | 0.9g | -7.1% | 97.14% | Lab B |
| 17 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.0 | 2mg | 2.2mg | +10.3% | 97.67% | Lab B |
| 17 May 2026 | Estradiol Cypionate | 5.6 | 300mg/ml | 317.4mg/ml | +5.8% | 95.92% | Lab B |
| 17 May 2026 | HCG | 5.8 | 15mg | 15.6mg | +3.9% | 96.57% | Lab A |
| 17 May 2026 | MGF | 7.2 | 15mg | 17.9mg | +19.7% | 96.35% | Lab A |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.2 | 2mg | 2.3mg | +16.1% | 96.42% | Lab E |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.9 | 50mg | 46.0mg | -8.1% | 95.67% | Lab B |
| 17 May 2026 | Ostarine (MK-2866) | 6.9 | 25mg | 22.8mg | -8.8% | 97.21% | Lab E |
| 17 May 2026 | PE 22-28 | 7.9 | 50mg | 57.8mg | +15.5% | 96.29% | Lab A |
| 17 May 2026 | PEG MGF | 6.4 | 15mg | 16.7mg | +11.4% | 98.31% | Lab G |
| 17 May 2026 | T3 (Liothyronine) | 7.2 | 50mg | 45.6mg | -8.8% | 95.00% | Lab D |
| 29 Jan 2026 | Dermorphin | 7.6 | 10mg | 11.3mg | +13.1% | 95.97% | Lab D |
| 29 Jan 2026 | Dianabol Raw | 6.2 | 5g | 4.8g | -4.1% | 95.19% | Lab F |
| 29 Jan 2026 | LGD-4033 (Ligandrol) Raw | 8.2 | 500g | 579.2g | +15.8% | 97.30% | Lab B |
| 29 Jan 2026 | MGF | 4.8 | 50mg | 52.7mg | +5.5% | 97.35% | Lab E |
| 29 Jan 2026 | MGF | 5.7 | 10mg | 12.2mg | +21.7% | 95.04% | Lab A |
| 29 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.3 | 50mg | 45.7mg | -8.5% | 97.57% | Lab D |
| 29 Jan 2026 | PE 22-28 | 8.5 | 50mg | 43.4mg | -13.3% | 95.80% | Lab D |
| 29 Jan 2026 | Trenbolone Acetate Raw | 7.6 | 100g | 109.3g | +9.3% | 95.07% | Lab G |
| 26 Jan 2026 | BAM15 | 7.1 | 100mg | 90.9mg | -9.1% | 98.92% | Lab F |
| 26 Jan 2026 | BPC-157 Arg Oral | 5.8 | 10mg | 9.0mg | -9.6% | 99.80% | Lab D |
| 26 Jan 2026 | Estradiol Cypionate | 8.7 | 200mg/ml | 235.0mg/ml | +17.5% | 97.67% | Lab E |
| 26 Jan 2026 | Estradiol Cypionate | 6.1 | 100mg/ml | 85.2mg/ml | -14.8% | 96.90% | Lab B |
| 26 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.4 | 10mg | 9.9mg | -1.3% | 97.27% | Lab D |
| 26 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.2 | 50mg | 54.4mg | +8.7% | 98.71% | Lab G |
| 26 Jan 2026 | PEG MGF | 8.4 | 15mg | 14.4mg | -4.2% | 97.09% | Lab A |
| 26 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.0 | 10g | 9.8g | -2.0% | 97.30% | Lab B |
| 26 Jan 2026 | Proviron (Mesterolone) | 8.7 | 25mg | 28.1mg | +12.2% | 96.51% | Lab E |
| 26 Jan 2026 | T3 (Liothyronine) | 7.7 | 25mg | 24.2mg | -3.0% | 97.67% | Lab D |
| 26 Jan 2026 | T3 (Liothyronine) | 7.5 | 50mg | 54.5mg | +8.9% | 99.08% | Lab D |
| 19 Jan 2026 | 17a-Methyl-1-Testosterone | 6.9 | 100mg | 121.1mg | +21.1% | 99.56% | Lab B |
| 19 Jan 2026 | 17a-Methyl-1-Testosterone | 8.0 | 20mg | 22.7mg | +13.6% | 99.14% | Lab F |
| 19 Jan 2026 | BAM15 | 7.7 | 10mg | 9.0mg | -10.2% | 98.14% | Lab B |
| 19 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.1 | 5mg | 6.2mg | +23.9% | 96.97% | Lab F |
| 19 Jan 2026 | HCG | 8.3 | 20mg | 19.4mg | -2.8% | 95.09% | Lab A |
| 19 Jan 2026 | Trenbolone Acetate Raw | 7.1 | 10g | 10.2g | +2.3% | 97.37% | Lab C |
| 9 Jan 2026 | 17a-Methyl-1-Testosterone | 7.5 | 25mg | 27.6mg | +10.2% | 99.24% | Lab E |
| 9 Jan 2026 | Anadrol Oil | 4.8 | 300mg/ml | 319.0mg/ml | +6.3% | 95.74% | Lab D |
| 9 Jan 2026 | Dianabol Raw | 7.2 | 100g | 122.4g | +22.4% | 98.31% | Lab B |
| 9 Jan 2026 | DSIP | 7.8 | 30mg | 37.2mg | +24.0% | 98.07% | Lab G |
| 9 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.2 | 5mg | 5.2mg | +3.1% | 97.26% | Lab D |
| 9 Jan 2026 | N-Acetyl Epitalon Amidate | 7.3 | 30mg | 30.6mg | +2.0% | 99.51% | Lab F |
| 9 Jan 2026 | Ostarine (MK-2866) | 8.0 | 20mg | 20.2mg | +1.2% | 99.16% | Lab E |
| 9 Jan 2026 | Proviron (Mesterolone) | 8.4 | 25mg | 21.3mg | -14.9% | 97.02% | Lab C |
| 9 Jan 2026 | T3 (Liothyronine) | 6.8 | 10mg | 10.3mg | +2.7% | 98.65% | Lab F |
| 9 Jan 2026 | Trenbolone Acetate Raw | 7.7 | 5g | 5.9g | +18.5% | 99.37% | Lab G |
| 7 Jan 2026 | 17a-Methyl-1-Testosterone | 4.6 | 100mg | 93.9mg | -6.1% | 99.05% | Lab C |
| 7 Jan 2026 | HCG | 5.9 | 15mg | 17.5mg | +16.7% | 97.24% | Lab B |
| 7 Jan 2026 | Lipo-B 216mg | 8.0 | 100mg/ml | 107.7mg/ml | +7.7% | 97.29% | Lab F |
| 7 Jan 2026 | Ostarine (MK-2866) | 8.9 | 10mg | 11.8mg | +18.1% | 95.47% | Lab A |
| 7 Jan 2026 | SNAP-8 | 7.2 | 50mg | 58.3mg | +16.7% | 99.29% | Lab G |
| 7 Jan 2026 | Trenbolone Acetate Raw | 4.8 | 5g | 5.9g | +18.3% | 99.82% | Lab D |
| 6 Jan 2026 | N-Acetyl Epitalon Amidate | 6.1 | 50mg | 50.4mg | +0.9% | 98.54% | Lab C |
| 6 Jan 2026 | Ostarine (MK-2866) | 5.9 | 20mg | 18.3mg | -8.4% | 99.98% | Lab B |
| 6 Jan 2026 | Ostarine (MK-2866) | 6.8 | 25mg | 29.4mg | +17.8% | 95.25% | Lab E |
| 6 Jan 2026 | P21 | 8.0 | 30mg | 34.3mg | +14.3% | 96.54% | Lab G |
| 6 Jan 2026 | P21 | 8.7 | 10mg | 11.9mg | +18.6% | 99.46% | Lab F |
| 6 Jan 2026 | PE 22-28 | 6.6 | 2mg | 1.8mg | -9.2% | 97.13% | Lab D |
| 6 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 6.1 | 5g | 5.6g | +11.5% | 97.02% | Lab E |
| 6 Jan 2026 | Proviron (Mesterolone) | 7.3 | 25mg | 22.0mg | -12.2% | 95.47% | Lab C |
| 6 Jan 2026 | T3 (Liothyronine) | 8.0 | 20mg | 18.7mg | -6.3% | 99.46% | Lab F |
| 29 Dec 2025 | BPC-157 Arg Oral | 6.3 | 50mg | 45.2mg | -9.7% | 95.41% | Lab D |
| 29 Dec 2025 | BPC-157 Arg Oral | 6.9 | 25mg | 27.2mg | +8.7% | 97.47% | Lab G |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.0 | 30mg | 36.8mg | +22.7% | 97.82% | Lab E |
| 29 Dec 2025 | Clenbuterol | 7.4 | 50mg | 62.2mg | +24.4% | 98.32% | Lab A |
| 29 Dec 2025 | Dermorphin | 4.9 | 5mg | 5.1mg | +2.2% | 98.57% | Lab C |
| 29 Dec 2025 | LGD-4033 (Ligandrol) Raw | 6.5 | 10g | 10.1g | +0.6% | 99.94% | Lab B |
| 29 Dec 2025 | Livagen | 5.9 | 50mg | 56.6mg | +13.2% | 98.29% | Lab D |
| 29 Dec 2025 | MGF | 6.8 | 15mg | 16.6mg | +10.9% | 97.54% | Lab F |
| 29 Dec 2025 | P21 | 8.6 | 15mg | 16.0mg | +6.5% | 97.46% | Lab F |
| 29 Dec 2025 | Proviron (Mesterolone) | 7.1 | 50mg | 51.5mg | +3.1% | 95.46% | Lab C |
| 29 Dec 2025 | T3 (Liothyronine) | 5.0 | 100mg | 97.6mg | -2.4% | 98.59% | Lab B |
| 12 Dec 2025 | 17a-Methyl-1-Testosterone | 8.7 | 20mg | 20.6mg | +3.0% | 97.91% | Lab A |
| 12 Dec 2025 | Anadrol Oil | 5.2 | 300mg/ml | 372.4mg/ml | +24.1% | 95.75% | Lab E |
| 12 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.9 | 10mg | 10.1mg | +0.8% | 96.68% | Lab E |
| 12 Dec 2025 | Lipo-B 216mg | 7.9 | 200mg/ml | 192.5mg/ml | -3.8% | 96.87% | Lab D |
| 12 Dec 2025 | Methylstenbolone | 8.2 | 10mg | 11.9mg | +19.4% | 96.91% | Lab E |
| 12 Dec 2025 | MOTS-C | 8.0 | 30mg | 27.9mg | -7.1% | 95.67% | Lab B |
| 12 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.8 | 20mg | 20.7mg | +3.3% | 97.43% | Lab B |
| 12 Dec 2025 | PEG MGF | 6.0 | 10mg | 10.0mg | -0.2% | 95.81% | Lab G |
| 12 Dec 2025 | SNAP-8 | 7.1 | 2mg | 1.9mg | -7.1% | 96.57% | Lab C |
| 5 Dec 2025 | 17a-Methyl-1-Testosterone | 7.1 | 50mg | 58.5mg | +16.9% | 98.37% | Lab D |
| 5 Dec 2025 | BAM15 | 8.0 | 100mg | 119.8mg | +19.8% | 99.68% | Lab C |
| 5 Dec 2025 | Clenbuterol | 6.0 | 50mg | 62.3mg | +24.5% | 97.61% | Lab F |
| 5 Dec 2025 | Estradiol Cypionate | 8.0 | 100mg/ml | 119.2mg/ml | +19.2% | 97.07% | Lab D |
| 5 Dec 2025 | LGD-4033 (Ligandrol) Raw | 7.7 | 1g | 1.1g | +11.0% | 96.28% | Lab A |
| 5 Dec 2025 | Methylstenbolone | 5.9 | 50mg | 46.3mg | -7.4% | 95.14% | Lab E |
| 5 Dec 2025 | Methylstenbolone | 9.3 | 10mg | 8.8mg | -11.8% | 98.49% | Lab F |
| 5 Dec 2025 | P21 | 7.8 | 2mg | 2.2mg | +9.6% | 97.93% | Lab F |
| 5 Dec 2025 | PE 22-28 | 7.5 | 2mg | 1.9mg | -6.1% | 99.31% | Lab E |
| 5 Dec 2025 | PTD-DBM | 6.4 | 15mg | 13.8mg | -8.0% | 99.49% | Lab C |
| 5 Dec 2025 | SNAP-8 | 9.4 | 2mg | 1.7mg | -14.0% | 97.78% | Lab B |
| 5 Dec 2025 | Tirzepatide 30mg Pen Kit | 6.5 | 30mg | 32.4mg | +8.0% | 99.53% | Lab A |
| 23 Nov 2025 | 17a-Methyl-1-Testosterone | 6.3 | 20mg | 17.6mg | -11.9% | 99.22% | Lab G |
| 23 Nov 2025 | Dermorphin | 6.9 | 50mg | 48.2mg | -3.7% | 95.78% | Lab A |
| 23 Nov 2025 | DSIP | 8.9 | 30mg | 29.5mg | -1.5% | 96.02% | Lab A |
| 23 Nov 2025 | Lipo-B 216mg | 8.2 | 300mg/ml | 362.5mg/ml | +20.8% | 95.20% | Lab D |
| 23 Nov 2025 | Proviron (Mesterolone) | 7.5 | 50mg | 49.2mg | -1.5% | 97.99% | Lab E |
| 23 Nov 2025 | T3 (Liothyronine) | 7.4 | 10mg | 10.4mg | +3.8% | 99.82% | Lab B |
| 17 Nov 2025 | 17a-Methyl-1-Testosterone | 7.7 | 20mg | 19.2mg | -3.9% | 95.40% | Lab D |
| 17 Nov 2025 | Dermorphin | 7.1 | 50mg | 52.4mg | +4.8% | 96.53% | Lab B |
| 17 Nov 2025 | HCG | 6.3 | 10mg | 11.9mg | +18.5% | 95.08% | Lab C |
| 17 Nov 2025 | P21 | 8.5 | 2mg | 2.2mg | +12.1% | 95.68% | Lab F |
| 17 Nov 2025 | PE 22-28 | 6.3 | 5mg | 5.9mg | +18.4% | 99.30% | Lab F |
| 17 Nov 2025 | S-23 Raw | 5.4 | 10g | 9.7g | -2.7% | 97.12% | Lab C |
| 17 Nov 2025 | SNAP-8 | 6.6 | 30mg | 33.8mg | +12.8% | 95.45% | Lab E |
| 14 Nov 2025 | BAM15 | 6.5 | 50mg | 54.8mg | +9.5% | 97.47% | Lab B |
| 14 Nov 2025 | BAM15 | 4.5 | 50mg | 47.2mg | -5.6% | 95.83% | Lab D |
| 14 Nov 2025 | Clenbuterol | 6.6 | 25mg | 21.9mg | -12.2% | 96.35% | Lab F |
| 14 Nov 2025 | Dianabol Raw | 6.2 | 5g | 5.6g | +12.3% | 95.54% | Lab A |
| 14 Nov 2025 | DSIP | 6.7 | 15mg | 17.8mg | +18.9% | 95.95% | Lab D |
| 14 Nov 2025 | Estradiol Cypionate | 8.5 | 100mg/ml | 99.3mg/ml | -0.7% | 96.97% | Lab D |
| 14 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.8 | 10mg | 9.1mg | -8.6% | 95.36% | Lab G |
| 14 Nov 2025 | HCG | 7.3 | 5mg | 5.8mg | +16.3% | 95.64% | Lab C |
| 14 Nov 2025 | LGD-4033 (Ligandrol) Raw | 7.6 | 10g | 9.6g | -4.3% | 98.18% | Lab A |
| 14 Nov 2025 | Methylstenbolone | 8.1 | 10mg | 11.5mg | +15.2% | 99.24% | Lab D |
| 14 Nov 2025 | Minoxidil Oral | 6.9 | 20mg | 19.7mg | -1.6% | 96.81% | Lab F |
| 14 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.9 | 30mg | 25.5mg | -14.9% | 99.39% | Lab E |
| 14 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 5.1 | 5g | 4.3g | -14.5% | 95.18% | Lab D |
| 14 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.7 | 5g | 5.9g | +17.6% | 97.54% | Lab B |
| 14 Nov 2025 | T3 (Liothyronine) | 6.2 | 10mg | 10.8mg | +8.1% | 97.25% | Lab C |
| 14 Nov 2025 | Tirzepatide 30mg Pen Kit | 8.3 | 10mg | 10.0mg | -0.2% | 99.85% | Lab A |
| 14 Nov 2025 | Trenbolone Acetate Raw | 7.0 | 5g | 5.7g | +14.5% | 97.47% | Lab E |
| 5 Nov 2025 | 17a-Methyl-1-Testosterone | 6.3 | 50mg | 43.5mg | -12.9% | 97.51% | Lab A |
| 5 Nov 2025 | Arimidex (Anastrozole) | 8.3 | 25mg | 30.3mg | +21.3% | 99.41% | Lab B |
| 5 Nov 2025 | BAM15 | 4.9 | 50mg | 56.7mg | +13.3% | 98.58% | Lab B |
| 5 Nov 2025 | BPC-157 Arg Oral | 7.6 | 20mg | 21.6mg | +8.2% | 96.39% | Lab F |
| 5 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.9 | 1g | 1.1g | +9.2% | 97.62% | Lab D |
| 5 Nov 2025 | T3 (Liothyronine) | 9.3 | 10mg | 11.5mg | +14.7% | 95.40% | Lab B |
| 5 Nov 2025 | Tirzepatide 30mg Pen Kit | 6.5 | 50mg | 50.5mg | +1.0% | 98.26% | Lab A |
| 5 Nov 2025 | Trenbolone Acetate Raw | 5.3 | 10g | 9.2g | -8.5% | 99.46% | Lab F |
| 4 Nov 2025 | Anadrol Oil | 6.1 | 200mg/ml | 226.1mg/ml | +13.0% | 97.16% | Lab A |
| 4 Nov 2025 | Clenbuterol | 7.4 | 100mg | 85.6mg | -14.4% | 99.03% | Lab A |
| 4 Nov 2025 | MOTS-C | 7.4 | 50mg | 46.6mg | -6.7% | 95.90% | Lab C |
| 4 Nov 2025 | Ostarine (MK-2866) | 5.3 | 50mg | 58.0mg | +16.0% | 99.55% | Lab B |
| 4 Nov 2025 | PEG MGF | 6.7 | 10mg | 8.8mg | -12.3% | 97.18% | Lab F |
| 17 Oct 2025 | AOD9604 | 5.6 | 20mg | 19.0mg | -4.8% | 95.64% | Lab E |
| 17 Oct 2025 | HCG | 8.7 | 15mg | 15.0mg | -0.0% | 97.53% | Lab E |
| 17 Oct 2025 | Minoxidil Oral | 7.9 | 50mg | 58.6mg | +17.2% | 96.82% | Lab A |
| 17 Oct 2025 | Minoxidil Oral | 7.2 | 20mg | 23.3mg | +16.7% | 96.45% | Lab A |
| 17 Oct 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 5.3 | 500g | 506.8g | +1.4% | 97.58% | Lab E |
| 17 Oct 2025 | T3 (Liothyronine) | 8.3 | 100mg | 104.1mg | +4.1% | 99.09% | Lab A |
| 17 Oct 2025 | T3 (Liothyronine) | 7.1 | 20mg | 20.1mg | +0.3% | 95.95% | Lab C |
| 17 Oct 2025 | Trenbolone Acetate Raw | 8.9 | 1g | 1.1g | +5.2% | 95.72% | Lab E |
| 9 Oct 2025 | BPC-157 Arg Oral | 5.2 | 100mg | 119.9mg | +19.9% | 99.37% | Lab A |
| 9 Oct 2025 | Clenbuterol | 7.3 | 25mg | 27.1mg | +8.2% | 99.55% | Lab B |
| 9 Oct 2025 | Clenbuterol | 6.7 | 100mg | 96.8mg | -3.2% | 99.77% | Lab A |
| 9 Oct 2025 | Dianabol Raw | 8.6 | 10g | 10.3g | +3.1% | 96.28% | Lab C |
| 9 Oct 2025 | P21 | 6.7 | 2mg | 1.9mg | -4.3% | 95.30% | Lab E |
| 3 Oct 2025 | AOD9604 | 6.3 | 30mg | 28.7mg | -4.4% | 96.52% | Lab G |
| 3 Oct 2025 | BPC-157 Arg Oral | 6.6 | 50mg | 42.7mg | -14.6% | 98.27% | Lab B |
| 3 Oct 2025 | BPC-157 Arg Oral | 9.6 | 25mg | 30.8mg | +23.1% | 96.27% | Lab G |
| 3 Oct 2025 | Clenbuterol | 5.4 | 100mg | 100.5mg | +0.5% | 95.75% | Lab A |
| 3 Oct 2025 | Estradiol Cypionate | 7.3 | 100mg/ml | 88.0mg/ml | -12.0% | 95.69% | Lab F |
| 3 Oct 2025 | LGD-4033 (Ligandrol) Raw | 5.6 | 1g | 1.1g | +10.0% | 96.05% | Lab G |
| 3 Oct 2025 | P21 | 7.0 | 10mg | 12.3mg | +22.7% | 99.30% | Lab A |
| 3 Oct 2025 | PE 22-28 | 5.3 | 50mg | 56.4mg | +12.7% | 97.24% | Lab E |
| 3 Oct 2025 | T3 (Liothyronine) | 5.1 | 100mg | 91.1mg | -8.9% | 95.02% | Lab C |